News Search Year - Any - 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2009 2008 Archive October 4, 2012 Deciphera Pharmaceuticals Announces Transition to an Oncology Drug Development Company Archive August 29, 2012 Deciphera Pharmaceuticals Announces Approval of rebastinib patent in Japan Archive June 11, 2012 Deciphera Pharmacueticals Announces Appointment of Kapil Bhalla, MD to its Scientific Advisory Board Archive April 26, 2012 Deciphera Pharmaceuticals Announces Appointment of Dr. Patrick O’Connor to its Scientific Advisory Board Archive February 1, 2012 Deciphera Pharmaceuticals Announces Collaboration Milestone with Eli Lilly and Company Archive July 18, 2011 Kansas Biosciences Authority Votes in Favor of a $1.6MM Product Development Grant to Deciphera Archive July 6, 2011 Deciphera Pharmaceuticals and the University of Kansas Cancer Center team up for clinical study of leukemia drug Archive April 18, 2011 Deciphera Pharmaceuticals Announces DCC-2036 research for CML published in Cancer Cell Archive January 17, 2011 Deciphera Pharmaceuticals Announces Extension of BRAF collaboration and Receipt of Development Milestone from Eli Lilly and Company Archive April 7, 2009 Deciphera Pharmaceuticals announces initiation of DCC-2036 Phase 1 Clinical Trial in Refractory CML and All
Archive October 4, 2012 Deciphera Pharmaceuticals Announces Transition to an Oncology Drug Development Company
Archive June 11, 2012 Deciphera Pharmacueticals Announces Appointment of Kapil Bhalla, MD to its Scientific Advisory Board
Archive April 26, 2012 Deciphera Pharmaceuticals Announces Appointment of Dr. Patrick O’Connor to its Scientific Advisory Board
Archive February 1, 2012 Deciphera Pharmaceuticals Announces Collaboration Milestone with Eli Lilly and Company
Archive July 18, 2011 Kansas Biosciences Authority Votes in Favor of a $1.6MM Product Development Grant to Deciphera
Archive July 6, 2011 Deciphera Pharmaceuticals and the University of Kansas Cancer Center team up for clinical study of leukemia drug
Archive April 18, 2011 Deciphera Pharmaceuticals Announces DCC-2036 research for CML published in Cancer Cell
Archive January 17, 2011 Deciphera Pharmaceuticals Announces Extension of BRAF collaboration and Receipt of Development Milestone from Eli Lilly and Company
Archive April 7, 2009 Deciphera Pharmaceuticals announces initiation of DCC-2036 Phase 1 Clinical Trial in Refractory CML and All
